Predictions
SPI Energy Co Ltd ADR
Start price
Target price
Perf. (%)
€6.65
22.12.20
22.12.20
€9.90
22.12.21
22.12.21
-24.03%
19.04.21
19.04.21
Valuable balance sheet
Capable Management
Sustainability is not important
ROE lower than 10% per year
Scatec Solar ASA
Start price
Target price
Perf. (%)
€29.92
20.12.20
20.12.20
€38.00
20.12.21
20.12.21
-50.69%
21.12.21
21.12.21
Could be very worthwhile Investment >20% year
BHP Group plc
Start price
Target price
Perf. (%)
€21.63
18.12.20
18.12.20
€26.00
18.12.21
18.12.21
17.66%
14.12.21
14.12.21
Could be worthwhile Investment >10% per year
Very high dividend yield expected
Undervalued
Higher EBIT margin than peer group
Sektkellerei Schloss Wachenheim AG
Start price
Target price
Perf. (%)
€15.10
18.12.20
18.12.20
€17.00
0.00%
22.02.21
22.02.21
CBAK Energy Technology Inc
Start price
Target price
Perf. (%)
€4.14
18.12.20
18.12.20
€4.00
-2.90%
18.12.20
18.12.20
Revenue growth >5% per year expected
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Standard Investments for future growth
CBAK Energy Technology Inc
Start price
Target price
Perf. (%)
€4.12
18.12.20
18.12.20
€3.00
0.49%
18.12.20
18.12.20
Revenue growth >5% per year expected
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Standard Investments for future growth
Plug Power Inc.
Start price
Target price
Perf. (%)
€24.98
18.12.20
18.12.20
€140.00
18.12.21
18.12.21
3.28%
19.12.21
19.12.21
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Medigene AG
Start price
Target price
Perf. (%)
€3.56
18.12.20
18.12.20
-
18.12.21
18.12.21
8.86%
27.02.21
27.02.21
Innovative
Dependend from some customers or products
Higher risks for its business
CBAK Energy Technology Inc
Start price
Target price
Perf. (%)
€3.84
17.12.20
17.12.20
€3.00
7.29%
18.12.20
18.12.20
Revenue growth >5% per year expected
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Standard Investments for future growth
Harmony Gold Mining ADR
Start price
Target price
Perf. (%)
€4.00
17.12.20
17.12.20
-
17.12.21
17.12.21
-15.75%
18.12.21
18.12.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
CBAK Energy Technology Inc
Start price
Target price
Perf. (%)
€4.28
16.12.20
16.12.20
€5.00
-10.28%
17.12.20
17.12.20
Revenue growth >5% per year expected
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Standard Investments for future growth
Vossloh AG
Start price
Target price
Perf. (%)
€42.25
16.12.20
16.12.20
€49.00
16.12.21
16.12.21
3.67%
17.12.21
17.12.21
Could be very worthwhile Investment >20% year
CBAK Energy Technology Inc
Start price
Target price
Perf. (%)
€4.22
16.12.20
16.12.20
€4.00
1.42%
16.12.20
16.12.20
Revenue growth >5% per year expected
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Standard Investments for future growth
Avinger Inc.
Start price
Target price
Perf. (%)
€4.88
14.12.20
14.12.20
€20.00
301.64%
11.01.21
11.01.21
Could be worthwhile Investment >10% per year
ElringKlinger AG
Start price
Target price
Perf. (%)
€14.22
14.12.20
14.12.20
€15.00
2.11%
15.12.20
15.12.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Stable Large shareholder and/or long term investor
Nuwellis Inc.
Start price
Target price
Perf. (%)
€6.00
14.12.20
14.12.20
€8.00
14.12.21
14.12.21
6.67%
11.01.21
11.01.21
Could be very worthwhile Investment >20% year
CBAK Energy Technology Inc
Start price
Target price
Perf. (%)
€4.06
14.12.20
14.12.20
€4.00
3.94%
16.12.20
16.12.20
Revenue growth >5% per year expected
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Standard Investments for future growth
Anpac Bio-Medical Science Co.
Start price
Target price
Perf. (%)
€106.00
14.12.20
14.12.20
€240.00
14.12.21
14.12.21
-15.09%
29.01.21
29.01.21
Could be worthwhile Investment >10% per year
Good culture
Growths slower than the competition
Dependend from some customers or products
Zumtobel AG
Start price
Target price
Perf. (%)
€6.10
14.12.20
14.12.20
€7.00
6.39%
17.03.21
17.03.21
Known brand
Could be worthwhile Investment >10% per year
Capable Management
Future proof or reliable business model
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€3.06
13.12.20
13.12.20
-
13.12.21
13.12.21
1.50%
11.03.21
11.03.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected